Suppr超能文献

B 族 G 蛋白偶联受体与 RAMP 复合物的第三细胞外环和 8 螺旋的功能及其受体运输的特性。

Functions of third extracellular loop and helix 8 of Family B GPCRs complexed with RAMPs and characteristics of their receptor trafficking.

机构信息

Frontier Science Research Center, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, Miyazaki 889-1692, Japan.

出版信息

Curr Protein Pept Sci. 2013 Aug;14(5):416-28. doi: 10.2174/13892037113149990058.

Abstract

At least one of three receptor activity-modifying proteins (RAMP1, RAMP2 and RAMP3) can interact with 10 G protein-coupled receptors (GPCRs; nine Family B GPCRs and a Family C GPCR). All three RAMPs interact with the calcitonin (CT) receptor (CTR), the CTR-like receptor (CLR), the vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating polypeptide (PACAP) 1 (VPAC1) and the VPAC2 receptor, which are all Family B GPCRs. Three RAMPs enable CTR to function as three heterodimeric receptors for amylin, which is a feeding suppression peptide. These RAMPs also transport the CLR to the cell surface, where they function as a CT gene-related peptide (CGRP) receptor (CLR/RAMP1 heterodimer) and two adrenomedullin (AM) receptors (CLR/RAMP2 and CLR/RAMP3 heterodimers). CGRP and AM are potent hypotensive peptides that exert powerful protective effects against multi-organ damage. We recently reported that the third extracellular loop (ECL3) of CLR governs the activation of AM, but not CGRP, signaling in the three CLR/RAMP heterodimers. Furthermore, we showed that in the presence of RAMP2, the eighth helix (helix 8) in the proximal portion of the cytoplasmic C-terminal tail of the CLR, which is thought to be present in all family B GPCRs, participates in receptor signaling. In addition, we demonstrated that overexpression of GPCR kinase (GRK) 2, GRK3 and GRK4 enhances the AM-induced internalization of the CLR/RAMP2 heterodimer. In this review, we describe these studies and consider their implications for other Family B GPCRs that can interact with RAMPs.

摘要

至少有三种受体活性修饰蛋白(RAMP1、RAMP2 和 RAMP3)之一可以与 10 种 G 蛋白偶联受体(GPCR;九种 B 族 GPCR 和一种 C 族 GPCR)相互作用。所有三种 RAMP 都与降钙素(CT)受体(CTR)、类似降钙素受体(CLR)、血管活性肠肽(VIP)/垂体腺苷酸环化酶激活肽(PACAP1)(VPAC1)和 VPAC2 受体相互作用,这些都是 B 族 GPCR。三种 RAMP 使 CTR 能够作为三种胰淀素(一种抑制进食的肽)的异源二聚体受体发挥作用。这些 RAMP 还将 CLR 转运到细胞表面,在那里它们作为 CT 基因相关肽(CGRP)受体(CLR/RAMP1 异源二聚体)和两种肾上腺髓质素(AM)受体(CLR/RAMP2 和 CLR/RAMP3 异源二聚体)发挥作用。CGRP 和 AM 是强效降压肽,对多器官损伤具有强大的保护作用。我们最近报道称,CLR 的第三个细胞外环(ECL3)调节 AM 的激活,但不调节 CGRP 信号,在三种 CLR/RAMP 异源二聚体中都是如此。此外,我们表明,在 RAMP2 存在的情况下,CLR 细胞质 C 端尾部近端部分的第八个螺旋(螺旋 8)参与受体信号转导,该螺旋被认为存在于所有 B 族 GPCR 中。此外,我们证明,G 蛋白偶联受体激酶(GRK)2、GRK3 和 GRK4 的过表达增强了 CLR/RAMP2 异源二聚体的 AM 诱导内化。在这篇综述中,我们描述了这些研究,并考虑了它们对其他可以与 RAMP 相互作用的 B 族 GPCR 的意义。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验